Point72 Middle East FZE’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Point72 Middle East FZE’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,658	Closed	-$4.2K	–	1443
2023 Q4	$4.2K	Buy	+1,658	New	+$3.86K	﹤0.01%	1429
2023 Q1	–	Sell	-6,748	Closed	-$16.9K	–	2350
2022 Q4	$16.9K	Buy	+6,748	New	+$18.8K	﹤0.01%	1667

Point72 Middle East FZE's SLGC Position: Q1 2024 in Review

Point72 Middle East FZE sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 1,658 shares — an estimated $4.2K sold.

Point72 Middle East FZE first reported a position in SLGC in Q4 2022 and held it in 2 quarters. The position peaked at $16.9K in Q4 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Point72 Middle East FZE reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 1,658 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $4.2K.
Point72 Middle East FZE first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2022 and held it in 2 quarters.
Point72 Middle East FZE's SomaLogic, Inc. Class A Common Stock position peaked at $16.9K in Q4 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.